Question · asked by 1 review

Oral ciprofloxacin and inhaled colistin vs inhaled tobramycin: Frequency of infective pulmonary exacerbations: number of exacerbations per patient year

Population
adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
Intervention
Oral ciprofloxacin and inhaled colistin
Comparison
inhaled tobramycin
Outcome
Frequency of infective pulmonary exacerbations: number of exacerbations per patient year

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Oral ciprofloxacin and inhaled colistin vs inhaled tobramycin (TNS)
Frequency of infective pulmonary exacerbations: number of exacerbations per patient year · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory…
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis (2023) · Cochrane Headline outcomes only
no estimate extracted1 study · 58 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
2023 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.